Recent update on pharmacokinetics and drug metabolism in CNS-based drug discovery

SN Sanap, AC Bisen, A Kedar… - Current …, 2023 - ingentaconnect.com
Despite significant advancements in CNS research, CNS illnesses are the most important
and serious cause of mental disability worldwide. These facts show a tremendous unmet …

[HTML][HTML] Overview of blood-brain barrier dysfunction in methamphetamine abuse

L Pang, Y Wang - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Methamphetamine (METH) is one of the psychostimulants most widely abused in the world.
METH abuse can lead to severe neurotoxicity. The blood-brain barrier (BBB) is a natural …

Breaking the Barriers: Machine-Learning-Based c-RASAR Approach for Accurate Blood–Brain Barrier Permeability Prediction

V Kumar, A Banerjee, K Roy - Journal of Chemical Information …, 2024 - ACS Publications
The intricate nature of the blood–brain barrier (BBB) poses a significant challenge in
predicting drug permeability, which is crucial for assessing central nervous system (CNS) …

Nanostructured lipid carriers for enhanced batimastat delivery across the blood–brain barrier: an in vitro study for glioblastoma treatment

M Horta, P Soares, B Sarmento, C Leite Pereira… - Drug Delivery and …, 2025 - Springer
Glioblastoma presents a significant treatment challenge due to the blood–brain barrier
(BBB) hindering drug delivery, and the overexpression of matrix metalloproteinases (MMPs) …

Dynamic tissue model in vitro and its application for assessment of microplastics-induced toxicity to air-blood barrier (ABB)

A Fu, S Mao, N Kasai, H Zhu, H Zeng - Biosensors and Bioelectronics, 2024 - Elsevier
The replication of the hominine physiological environment was identified as an effectual
strategy to develop the physiological model in vitro to perform the intuitionistic assessment of …

[HTML][HTML] A new frontier in neuropharmacology: recent progress in natural products research for blood–brain barrier crossing

UV Isabel, ARM Belén, GB Elena - Current Research in Biotechnology, 2024 - Elsevier
Neuropharmacology faces challenges due to the intricate nervous system, diverse
neurological disorders, and existence of the blood–brain barrier (BBB), which hinder the …

Brain organoids: A new tool for modelling of neurodevelopmental disorders

Y Aili, N Maimaitiming, Z Wang… - Journal of Cellular and …, 2024 - Wiley Online Library
Neurodevelopmental disorders are mostly studied using mice as models. However, the
mouse brain lacks similar cell types and structures as those of the human brain. In recent …

Experimental models to study the functions of the blood–brain barrier

A Łach, A Wnuk, AK Wójtowicz - Bioengineering, 2023 - mdpi.com
The purpose of this paper was to discuss the achievements of in vitro modeling in terms of
the blood–brain barrier [BBB] and to create a clear overview of this research area, which is …

Exosomes-encapsulated biomimetic polydopamine carbon dots with dual-targeting effect alleviate motor and non-motor symptoms of Parkinson's disease via anti …

C Yang, Y Song, M Luo, Q Wang, Y Zhang… - International Journal of …, 2025 - Elsevier
Currently, the clinical drugs for Parkinson's disease (PD) only focus on motor symptoms,
while non-motor symptoms like depression are usually neglected. Even though, the efficacy …

Brain organoid methodologies to explore mechanisms of disease in progressive multiple sclerosis

MBC Simões-Abade, M Patterer, AM Nicaise… - Frontiers in Cellular …, 2024 - frontiersin.org
Multiple sclerosis (MS), a debilitating autoimmune disorder targeting the central nervous
system (CNS), is marked by relentless demyelination and inflammation. Clinically, it …